Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Res Commun ; 34(1): 65-9, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20012189

ABSTRACT

Forty bitches in anoestrus for more than six months from the last heat, with a serum progesterone level less than 1 ng/ml were subjected to oestrus induction trials using anti-prolactin drugs and levothyroxine, once daily orally for 20 consecutive days. The mean serum progesterone level among them was found to be 0.57 +/- 0.03 ng/ml. Out of 10 animals treated in each group, five (50%) in Group I (bromocriptine @ 50 microg/kg body weight), nine (90%) in Group II (cabergoline @ 5 microg/kg body weight), eight (80%) in Group III (thyroxine @10 microg/kg body weight) and seven (70%) in Group IV (thyroxine @ 5 microg/kg body weight) responded by evincing proestrual bleeding. The mean (+/-SEM) time taken from initiation of treatment to onset of proestrual bleeding in Groups I, II, III and IV was 28 +/- 3.39, 13.44 +/- 3.12 (P < 0.05), 24.50 +/- 3.18 and 33 +/- 2.21 days respectively. The mean (+/-SEM) duration of proestrus and oestrus in the treatment groups was 9.80 +/- 0.86, 10.11 +/- 0.68, 11.25 +/- 0.88 and 10.71 +/- 0.68 days and 7.60 +/- 0.24, 8 +/- 0.29, 8.5 +/- 0.63 and 7.85 +/- 0.46 days respectively. The conception rate in relation to the number of animals responding to oestrus induction in the treatment groups was 80%, 78%, 63% and 57%, respectively. The mean (+/-SEM) gestation length calculated from the last breeding date and litter size in the treatment groups varied from 60.50 +/- 1.55 to 64.00 +/- 0.82 days and 5.14 +/- 0.34 to 6.40 +/- 0.40 respectively.


Subject(s)
Bromocriptine/pharmacology , Ergolines/pharmacokinetics , Estrous Cycle/drug effects , Fertilization/drug effects , Litter Size/drug effects , Thyroxine/pharmacology , Animals , Cabergoline , Dogs , Female , Hormone Antagonists/pharmacology , Progesterone/blood , Prolactin/antagonists & inhibitors , Prolactin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...